SUPN Market Cap & Key Metrics
Supernus Pharmaceuticals, Inc.
$41.01
+$0.83(+2.07%)
53
Overall
60
Value
40
Tech
60
Quality
Market Cap
$2.44B
Volume
51.34K
52W Range
$40.51 - $59.68
Target Price
$61.75
SUPN market cap is $2.44B. This page lists Supernus Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
SUPN Key Metrics
- Market cap
- $2.44B
- P/E ratio (current-year EPS estimate)
- 20.82
- EPS estimate, current year
- $1.97
- EPS growth, 3-year
- -100.00%
- Value score
- 60
- Quality score
- 60
- Technical score
- 40
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $718.95M | $661.82M | $607.52M | $667.24M | $579.77M |
| EBITDA | $50.51M | $183.74M | $90.58M | $150.94M | $146.69M |
| EPS | $-0.68 | $1.34 | $0.02 | $1.13 | $1.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SUPN | $41.01 | +2.1% | 51.34K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Supernus Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW